Disrupting the paradigm

As a woman-founded and led company with in-house manufacturing capabilities of its internally conceived portfolio of products, Femasys is well-positioned to deliver its solutions to the market with the achievement of global regulatory approvals.
Headshot photo of Melanie Thistle, VP of Business Development & Market Access

Melanie Thistle

Vice President, Business Development & Marketing

Ms. Thistle brings 30 years of U.S. and international commercial leadership that spans all aspects and phases of product commercialization within healthcare.  Most recently, Ms. Thistle served in commercial leadership roles for global molecular diagnostics company Exact Sciences (formerly Genomic Health) for more than a decade. Her roles included enterprise strategy, health policy, medical society partnerships, patient advocacy, reimbursement policy, and global training and development.  Through previous leadership roles with Natera, Biogen, and Genzyme, Ms. Thistle gained expertise in business development, sales, marketing, training, market research, and mergers and acquisitions. She has also established and led commercial strategy for technology start-up organizations, which pioneered an electronic prescribing tool for physicians and led U.S. and international channels for a technology consulting business across Europe, Australia, Asia, and the U.S.  Ms. Thistle holds a BA in Management from Regis College and an MBA from Suffolk University.